EMRISE Receives $1.2 Million in Orders for Electronic

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
EMRISE Receives $1.2 Million in Orders for Electronic Devices for In-Flight Entertainment and Connectivity (IFE&C) Systems

DURHAM, N.C., Oct. 30, 2013 (GLOBE NEWSWIRE) -- EMRISE CORPORATION (OTCQB:EMRI), a multi-national manufacturer of defense and aerospace electronic devices and communications equipment, today announced that it has received an aggregate of $1.2 million in orders from three customers for electronic devices for use in In-Flight Entertainment and Connectivity (IFE&C) systems to be installed in commercial aircraft. This group of orders includes a $500,000 order from its longest standing customer in the IFE&C market.

Ranging in size from $320,000 to $380,000 to $500,000, the three orders were received by the Company's Pascall Electronics Ltd. subsidiary in England. Shipments of the orders are expected to commence early next year and be completed by the end of 2014.

EMRISE Chairman and Chief Executive Officer Carmine T. Oliva said the industry-wide demand for advanced IFE&C systems from domestic and international carriers continues to be strong. He noted that the Company continues to receive a steady stream of orders in a range of sizes for this expanding market, which is having a positive impact on the size of the Company's backlog.

The shipment of new aircraft and the refurbishment of existing aircraft combined with the need to create additional revenue sources that improve a passenger's air travel experience are driving the global airline industry's increasing demand for new multimedia IFE&C systems.

"We believe the demand for IFE&C systems is also being favorably impacted by industry forecasts for increases in future aircraft deliveries," Oliva added. "As a supplier to major OEMs that provide advanced IFE&C systems to airlines, we are benefiting from that demand."

About EMRISE Corporation

EMRISE designs, manufactures and markets electronic devices, sub-systems and equipment for aerospace, defense, industrial and communications markets. EMRISE electronic devices products perform key functions such as power supply and power conversion, and radio frequency (RF) and microwave signal processing. Its electronic devices and communications equipment products are used in a range of applications including on-board In-Flight Entertainment and Connectivity systems, and network access to public and private communications networks. EMRISE serves its base of customers in Europe, North America and Asia through operations in England, France and the United States. For more information, go to www.emrise.com .

EMRISE common stock trades under the symbol EMRI on OTCQB. Real-Time quotes and Level 2 information for EMRISE stock can be found at www.otcmarkets.com , or on the Company's website at http://www.emrise.com/investor_relations/stoc.../index.htm .

Safe Harbor Statement under Private Securities Litigation Reform Act of 1995

With the exception of historical information, certain matters discussed in this press release, including but not limited to EMRISE's beliefs that shipments of the orders are to commence early next year and be completed by the end 2014; the industry-wide demand for advanced IFE&C systems from domestic and international carriers remains strong; the shipment of new aircraft and the refurbishment of existing aircraft combined with the need to create additional revenue sources that improve a passenger's air travel experience are driving the global airline industry's increasing demand for new multimedia IFE&C systems; this demand is also being favorably impacted by industry forecasts for increases in future aircraft deliveries; and as a supplier to major OEMs that provide advanced IFE&C systems to airlines, the Company continues to benefit from that demand, are all forward-looking statements involving risks and uncertainties. Actual future results of EMRISE could differ from those statements. EMRISE also refers you to those factors contained in the "Risk Factors" Section of EMRISE's Annual Report on Form 10-K for the year ended December 31, 2012, its Quarterly Reports on Form 10-Q, Current Reports on Form 8-K filed recently, and other EMRISE SEC filings.

Allen & Caron Inc Rene Caron or Jill Bertotti (investors) Len Hall (media) (949) 474-4300 or

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Angel Oak Mortgage Trust 2025-1 Receives Preliminary Ratings

Updated Category News Views 195

Angel Oak Mortgage Trust 2025-1 Ratings Overview KBRA has recently assigned preliminary ratings to various classes of mortgage-backed certificates associated with Angel Oak Mortgage Trust 2025-1 (AOMT 2025-1). This substantial transaction amounts to $342.0 million and comprises non-prime residential mortgage-backed securities (RMBS). It encompasses a pool of 631...

Continue Reading
Eagle Bancorp Montana Reports Positive Q3 Performance Growth

Updated Category News Views 177

Eagle Bancorp Montana's Strong Q3 Earnings Report Eagle Bancorp Montana, Inc. (NASDAQ: EBMT), the parent entity of Opportunity Bank of Montana, recently shared its financial results for the latest quarter. With net income reaching $2.7 million, or $0.34 per diluted share, this marks an upward trend from the previous quarter’s income of $1.7 million, equivalent to $0.22...

Continue Reading
Consumer Resilience Fuels Bank of America Amidst Slowing Trends

Updated Category News Views 310

Bank of America's Performance Overview Bank of America (NYSE: BAC) has reported a mixed performance in recent times, showing resilience in its earnings even as some sectors experience challenges. The bank's stock opened slightly higher, reflecting a cautious optimism in the market with shares trading around $46.50. For the quarter, Bank of America generated $26.6 billion...

Continue Reading
The Setai St. Maarten: A New Era in Caribbean Luxury

Updated Category News Views 136

The Setai St. Maarten: A Feast for the Senses In a stunning location along the coast, The Setai St. Maarten emerges as a jewel of luxury, introducing a captivating blend of elegance and tranquility to the Caribbean. This exciting new resort is poised to redefine the standards of Caribbean hospitality, creating unforgettable experiences for guests in a picturesque coastal...

Continue Reading
Cullinan Therapeutics Gears Up for Major Healthcare Events

Updated Category News Views 142

Cullinan Therapeutics Hosts Exciting Events at Major Conferences CAMBRIDGE, Mass. — Cullinan Therapeutics, Inc. (Nasdaq: CGEM), a prominent biopharmaceutical firm, is set to engage the investment community with notable events at the upcoming American Society of Clinical Oncology (ASCO) Annual Meeting and the Jefferies 2025 Global Healthcare Conference. These gatherings...

Continue Reading